Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Pharmacogenomics ; 22(9): 515-517, 2021 06.
Article in English | MEDLINE | ID: covidwho-1242272

ABSTRACT

The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.


Subject(s)
Congresses as Topic/trends , Health Services Accessibility/trends , Insurance, Health, Reimbursement/trends , Medical Assistance/trends , Pharmacogenetics/trends , District of Columbia , Health Personnel/economics , Health Personnel/trends , Health Services Accessibility/economics , Humans , Insurance, Health, Reimbursement/economics , Medical Assistance/economics , Pharmacogenetics/economics , Precision Medicine/economics , Precision Medicine/trends , Technology Assessment, Biomedical/economics , Technology Assessment, Biomedical/trends
3.
J Vasc Surg ; 72(6): 1856-1863, 2020 12.
Article in English | MEDLINE | ID: covidwho-863661

ABSTRACT

Although the coronavirus disease 2019 (COVID-19) pandemic has created havoc with the U.S healthcare system and physicians, the financial and contractual implications for physicians are now beginning to come to the forefront. Financial assistance from the federal government has mainly been received by hospitals, which have borne the brunt of the COVID-19 illness. Some physician groups have, or are, receiving assistance through a few programs, although the accelerated and advance payments have been suspended. Employed surgeons are now being furloughed, terminated, or persuaded to agree to a significant cut in pay, forego bonuses, or take leave without pay as healthcare systems and some physician groups have started to experience the consequences of halting elective procedures. Newly hired surgeons might be forced in a few cases to agree to delays in starting their employment, new amendments, changes in employment status, and other terms for fear of losing their employment. In the present report, we have explained some agreement terminology and options available to allow physicians to understand the terms of their employment agreement and make their decisions after consulting with an expert healthcare attorney.


Subject(s)
COVID-19/economics , Employment/economics , Financing, Government/economics , Income , Insurance, Health, Reimbursement/economics , Surgeons/economics , Ambulatory Care/economics , COVID-19/legislation & jurisprudence , Employment/legislation & jurisprudence , Financing, Government/legislation & jurisprudence , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Policy Making , Practice Management, Medical/economics , Surgeons/legislation & jurisprudence , Telemedicine/economics , Time Factors , United States
4.
J Mol Diagn ; 22(8): 967, 2020 08.
Article in English | MEDLINE | ID: covidwho-701298

ABSTRACT

This editorial highlights the article from the Association for Molecular Pathology's Economic Affairs Committee that appears in this issue.


Subject(s)
Insurance Coverage/economics , Insurance, Health, Reimbursement/economics , Laboratories, Hospital/economics , Molecular Diagnostic Techniques/economics , Humans , Patient Care/economics , Remuneration
5.
Curr Allergy Asthma Rep ; 20(10): 60, 2020 07 27.
Article in English | MEDLINE | ID: covidwho-679786

ABSTRACT

PURPOSE OF REVIEW: Telemedicine is a rapidly growing healthcare sector that can improve access to care for underserved populations and offer flexibility and convenience to patients and clinicians alike. However, uncertainty about insurance coverage and reimbursement policies for telemedicine has historically been a major barrier to adoption, especially among physicians in private practice (the majority of practicing allergists). RECENT FINDINGS: The COVID-19 public health emergency has highlighted the importance of telehealth as a safe and effective healthcare delivery model, with governments and payers rapidly expanding coverage and payment in an effort to ensure public access to healthcare in the midst of an infectious pandemic. This comprehensive review of updated telemedicine coverage and payment policies will include a tabular guide on how to appropriately bill and optimize reimbursement for telemedicine services. This review of current trends in telemedicine coverage, billing, and reimbursement will outline the historical and current state of telemedicine payment policies in the USA, with special focus on recent policy changes implemented in light of COVID-19. The authors will also explore the potential future landscape of telehealth coverage and reimbursement beyond the resolution of the public health emergency.


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Pneumonia, Viral/diagnosis , Pneumonia, Viral/therapy , Telemedicine/economics , Telemedicine/methods , Betacoronavirus/isolation & purification , COVID-19 , Clinical Coding , Coronavirus Infections/economics , Humans , Insurance, Health, Reimbursement/economics , Pandemics/economics , Pneumonia, Viral/economics , SARS-CoV-2
6.
J Vasc Surg ; 73(2): 392-398, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-628496

ABSTRACT

Implementation of telemedicine for patient encounters optimizes personal safety and allows for continuity of patient care. Embracing telehealth reduces the use of personal protective equipment and other resources consumed during in-person visits. The use of telehealth has increased to historic levels in response to the coronavirus disease 2019 (COVID-19) pandemic. Telehealth may be a key modality to fight against COVID-19, allowing us to take care of patients, conserve personal protective equipment, and protect health care workers all while minimizing the risk of viral spread. We must not neglect vascular health issues while the coronavirus pandemic continues to flood many hospitals and keep people confined to their homes. Patients are not immune to diseases and illnesses such as stroke, critical limb ischemia, and deep vein thrombosis while being confined to their homes and afraid to visit hospitals. Emerging from the COVID-19 crisis, incorporating telemedicine into routine medical care is transformative. By leveraging digital technology, the authors discuss their experience with the implementation, workflow, coding, and reimbursement issues of telehealth during the COVID-19 era.


Subject(s)
COVID-19 , Pandemics , Patient Care , Telemedicine , Vascular Diseases , Clinical Coding , Humans , Insurance, Health, Reimbursement/economics , Insurance, Health, Reimbursement/standards , Licensure, Medical , Mobile Applications , Patient Care/economics , Patient Care/methods , Patient Care/standards , Patient Selection , SARS-CoV-2 , Telemedicine/economics , Telemedicine/organization & administration , Telemedicine/standards , Telemedicine/trends , United States , United States Department of Veterans Affairs , Vascular Diseases/diagnosis , Vascular Diseases/economics , Vascular Diseases/therapy , Workflow
7.
J Vasc Surg ; 72(4): 1161-1165, 2020 10.
Article in English | MEDLINE | ID: covidwho-133517

ABSTRACT

The appropriate focus in managing the COVID-19 pandemic in the United States has been addressing access and delivery of care to the population affected by the outbreak. All sectors of the U.S. economy have been significantly affected, including physicians. Physician groups of all specialties and sizes have experienced the financial effects of the pandemic. Hospitals have received billions of dollars to support and enable them to manage emergencies and cover the costs of the disruption. However, many vascular surgeons are under great financial pressure because of the postponement of all nonemergency procedures. The federal government has announced a myriad of programs in the form of grants and loans to reimburse physicians for some of their expenses and loss of revenue. It is more than likely that unless the public health emergency subsides significantly, many practices will experience dire consequences without additional financial assistance. We have attempted to provide a concise listing of such programs and resources available to assist vascular surgeons who are small businesses in accessing these opportunities.


Subject(s)
Appointments and Schedules , Compensation and Redress , Coronavirus Infections/economics , Elective Surgical Procedures/economics , Income , Insurance, Health, Reimbursement/economics , Pandemics/economics , Pneumonia, Viral/economics , Surgeons/economics , Vascular Surgical Procedures/economics , COVID-19 , Compensation and Redress/legislation & jurisprudence , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Elective Surgical Procedures/legislation & jurisprudence , Financing, Government/economics , Financing, Government/legislation & jurisprudence , Health Services Needs and Demand/economics , Health Services Needs and Demand/legislation & jurisprudence , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Policy Making , Surgeons/legislation & jurisprudence , United States/epidemiology , Vascular Surgical Procedures/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL